Neurological complications associated with HIV and AIDS: Clinical implications for nursing

Journal of Neuroscience Nursing

Volumn 45, Issue 1, 2013, Pages 5-13

  Theroux, Nicole ^a   Phipps, Meredith ^a   Zimmerman, Lauren ^a   Relf, Michael V ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

AIDS; Cryptococcal meningitis; HIV; HIV associated dementia; Neurological complications; Nursing; Peripheral neuropathy; Toxoplasmosis

Indexed keywords

CRYPTOCOCCAL MENINGITIS; HIV ASSOCIATED DEMENTIA; HUMAN; METHODOLOGY; NURSING; NURSING DISCIPLINE; PERIPHERAL NEUROPATHY; REVIEW; TOXOPLASMOSIS;

AIDS DEMENTIA COMPLEX; HUMANS; MENINGITIS, CRYPTOCOCCAL; PERIPHERAL NERVOUS SYSTEM DISEASES; SPECIALTIES, NURSING; TOXOPLASMOSIS;

EID: 84873695125     PISSN: 08880395     EISSN: 19452810     Source Type: Journal    
DOI: 10.1097/JNN.0b013e318275b1b2     Document Type: Review

References (39)

1. Boulware, D. R., Meya, D. B., Bergemann, T. L., Wiesner, D. L., Rhein, J., Musubire, A., I Bohjanen, P. R. (2010). Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: A prospective cohort study. PLoS Medicine, 7(12), e1000384.
2. Busari, O. A., Deyemi, A. O., & Agboola, S. M. (2009). Cryptococcal meningitis in AIDS. Internet Journal of Infectious Diseases, 7, 1.
3. Center for Disease Control and Prevention. (2011a). 30 years of HIV and AIDS commemoration. Retrieved from: http://www.cdc.gov/Features/30yearsHIV/.
4. Center for Disease Control and Prevention. (2011b). HIV incidence. Retrieved from: http://www.cdc.gov/hiv/topics/surveillance/incidence.htm.
5. Center for Disease Control and Prevention. (2011c). Cryptoccocus fact sheet. Retrieved from: http://www.cdc.gov/ncezid/dfwed/factsheets/FACTSHEET- Cryptococcus-revised%205-17-2011.pdf.
6. Davis, H. F., Skolasky R. L. Jr., Selnes, O. A., Burgess, D. M., & McArthur, J. C. (2002). Assessing HIV-associated dementia: Modified HIV dementia scale versus the Grooved Pegboard. AIDS Reader, 12(1), 29Y31, 38.
7. Davis, S. (2010). Toxoplasmosis. In B. Swanson (Ed.), ANAC's core curriculum for HIV/AIDS nursing. Sudbury, MA: Jones and Bartlett.
8. Dorsey, S. G., & Morton, P. G. (2006). HIV peripheral neuropathy, pathophysiology and clinical implications. AACN Clinical Issues, 17(1), 30-36.
9. Ghafouri, M., Amini, S., Khalili, K., & Sawaya, B. E. (2006). HIV-1 associated dementia: Symptoms and causes [Research Support, N.I.H., Extramural Review]. Retrovirology, 3, 28. doi:10.1186/1742-4690-3-28.
10. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Survasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adult: Effect of patient age, cognitive status, and substance abuse. AIDS, 1, 19-25.
11. Howe, T. E., Rochester, L., Jackson, A., Banks, P.M. H., & Blair, V. A. (2007). Exercise for improving balance in older people. Cochrane Database of Systematic Reviews, Issue 4. Art. No. CD004963. doi:10.1002/14651858.CD004963. pub2.
12. Ignatavicius, D. D., & Workman, M. l. (2010). Medicalsurgical nursing: Patient-centered collaborative care (6th ed.). St. Louis, MO: Saunders Elsevier.
13. Keithley, J. (2010). Cognitive impairments. In B. Swanson (Ed.), ANAC's core curriculum for HIV and AIDS nursing (3rd ed.) Sudbury, MA: Jones and Bartlett .
14. Lackner, P., Kuenz, B., Reindl, M., Morandell, M., Berger, T., Scmutzhard, E., & Eggers, C. (2010). Antibodies to myelin oligodendrocyte glycoprotein in hiv-1 associated neurocognitive disorder: A cross-sectional cohort study. Journal of Neuroinflammation, 7, 79.
15. Levine, A. J., Hinkin, C. H, Ando, K., Santangelo, G., Martinez, M., Valdes-Sueiras, M., I Singer, E. (2008). An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV + adults. Journal of Clinical and Experimental Neuropsychology, 30(7), 836-843.
16. Masur, H. (1990). Problems in the management of opportunistic infections in patients infected with human immunodeficiency virus. Journal of Infectious Diseases, 161(5), 858-864.
17. Monroe, A. (2010). Understanding and managing peripheral neuropathy. Bulletin of Experimental Treatment for AIDS, Winter/Spring, 22(2), 27-35.
18. Montoya, J. G., & Liesenfeld, O. (2004). Toxoplasmosis. Lancet, 363(9425), 1965-1976.
19. Nicolas, P. K., Maucer, L., Ciampa, A. S., Coless, I.B., Raymond, N., Barry, D. J., & Viamonte, A. (2007). Distal sensory polyneuropathy in the context of HIV and AIDS. Journal of the Association of Nurses in AIDS Care, 18(4), 32-40.
20. Nicolas, P. K., Voss, J., Wantland, D., Lindgren, T., Huang, E., Holzemer, W. L., I Bain, C.A. (2010). Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV and AIDS. Nursing and Health Sciences, (12), 119-126.
21. Pereira-Chioccola, V. L., Vidal, J. E., & Su, C. (2009). Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiology, 4(10), 1363-1379.
22. Phillips, T. J. C., Cherry, C. L., Cox, S., Marshall, S. J., & Rice, A. S. C. (2010). Pharmacological treatment of painful HIVassociated sensory neuropathy: A systematic review and meta- analysis of randomised controlled trials. PloS ONE, 5(12), e14433.
23. Pynoos, J., Steinman, B. A., & Nguyen, A. Q. (2010). Environmental assessment and modification as fall-prevention strategies for older adults. Clinics in Geriatric Medicine, 26(4), 633-644.
24. Sacktor, N. C., Wong, M., Nakasujja, N., Skolasky, R. L., Selnes, O. A., Musisi, S., I Katabira, E. (2005). The International HIV Dementia Scale: A new rapid screening test for HIV dementia. AIDS, 19(13), 1367-1374. doi:00002030-200509020-00004 [pii].
25. Sandoval, R., Runft, B., & Roddey, T. (2010). Pilot study: Does lower extremity night splinting assist in the management of painful peripheral neuropathy in the HIV and AIDS population. Journal of the International Association in AIDS Care (JIAPAC), 9(6), 367-381.
26. Sibley, L. D., Mordue, D. G., Su, C., Robben, P. M., & Howe, D. K. (2002), Genetic approaches to studying virulence and pathogenesis in toxoplasma gondii. Philosophical Transactions: Biological Sciences, 357(1417), 81-88.
27. Simioni, S., Cavassini, M., Annoni, J.-M., Hirschel, B., & Du Pasquier, R. A. (2010). HIV-associated neurocognitive disorders: A changing pattern. Future Neurology, 6(1), 81-96.
28. Strazza, M., Pirrone, V., Wigdahl, B., & Nonnemacher, M. R. (2011). Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier. Brain Research, 1399, 96-115. doi:10.1016/j.brainres.2011.05.015.
29. The White House Office of AIDS Policy. (2010). National HIV and AIDS strategy for the United States. Retrieved from http://www.aids.gov/federal- resources/policies/nationalhiv-aids-strategy/#.
30. U.K. Collaborative HIV Cohort Study Steering Committee. (2010). HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. European Journal of Neurology, 18, 527-534.
31. U.S. Department of Health and Human Services. (2011a). HIVassociated dementia and other neurocognitive disorders. In Coffey, S. (Ed.) Guide for HIV and AIDS clinical care. Rockville, MD: Author.
32. U.S. Department of Health and Human Services. (2011b). Pain syndrome and peripheral neuropathy. In Coffey, S. (Ed.), Guide for HIV and AIDS clinical care. Rockville, MD: Author.
33. U.S. Department of Health and Human Services. (2011c). Neurologic symptoms. In Coffey, S. (Ed.), Guide for HIV and AIDS clinical care. Rockville, MD: Author.
34. U.S. Department of Health and Human Services. (2011d). Cryptococcal disease. In Coffey, S. (Ed.), Guide for HIV and AIDS clinical care. Rockville, MD: Author.
35. U.S. Department of Health and Human Services. (2011e). Toxoplasmosis. In Coffey, S. (Ed.), Guide for HIV and AIDS clinical care. Rockville, MD: Author.
36. U.S. Department of Health and Human Services. (2011f ). Adherence. In Coffey, S. (Ed.), Guide for HIV and AIDS clinical care. Rockville, MD: Author.
37. Vivithanaporn, P., Heo, G., Gamble, J., Krentz, H. B., Hoke, A., Gille, M. J., & Power, C. (2010). Neurologic disease burden in treated HIV and AIDS predicts survival, a populationbased study. Neurology, 75, 1-9.
38. World Health Organization. (2008). Scoping document for WHO treatment guideline on pain related to cancer, HIV and other progressive life-threatening illnesses in adults. Retrieved from http://www.who.int/medicines/areas/quality- safety/Scoping-WHOGuide-malignant-pain-adults.pdf.
39. Xia, C., Luo, D., Yu, X., Jiang, S., & Liu, S. (2011). HIVassociated dementia in the era of highly active antiretroviral therapy (HAART). Microbes and Infection/Institut Pasteur, 13(5), 419-425. doi:10.1016/j.micinf.2011.01. 004.